Items where authors include "Wardley, A.M."

Article

Ring, A. orcid.org/0000-0003-1230-2973, Kilburn, L.S. orcid.org/0000-0002-1987-7545, Pearson, A. orcid.org/0000-0002-5854-193X et al. (21 more authors) (2023) Olaparib and ceralasertib (AZD6738) in patients with triple-negative advanced breast cancer: Results from Cohort E of the plasmaMATCH trial (CRUK/15/010). Clinical Cancer Research, 29 (23). pp. 4751-4759. ISSN 1078-0432

Verrill, M., Wardley, A.M., Retzler, J. orcid.org/0000-0002-0008-3104 et al. (6 more authors) (2020) Health-related quality of life and work productivity in UK patients with HER2-positive breast cancer: a cross-sectional study evaluating the relationships between disease and treatment stage. Health and Quality of Life Outcomes, 18. 353. ISSN 1477-7525

Tutt, A., Tovey, H., Cheang, M.C.U. et al. (35 more authors) (2018) Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial. Nature Medicine, 24 (5). pp. 628-637. ISSN 1078-8956

Wardley, A.M., Hiller, L., Howard, H.C. et al. (8 more authors) (2008) tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluation. British Journal of Cancer, 99 (4). pp. 597-603. ISSN 0007-0920

Clayton, A.J., Danson, S., Jolly, S. et al. (9 more authors) (2004) Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer. British Journal of Cancer , 91 (4). pp. 639-643. ISSN 0007-0920